You are here
Hike in medication price leads to drop in demand
EARLY last year, drugmaker Mallinckrodt plc spent US$1.3 billion to buy a company that sold an injectable form of acetaminophen - essentially Tylenol in a liquid solution.
Within months, the new owner more than doubled the price of the drug, called Ofirmev. Revenue from
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org